Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function

Infection and Immunity

Volumn 76, Issue 4, 2008, Pages 1340-1348

  Johnson Henry, K C ^a   Donato, K A ^a,b   Shen Tu, G ^a   Gordanpour, M ^a   Sherman, P M ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; PROBIOTIC AGENT; PROTEIN ZO1; MEMBRANE PROTEIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CANCER CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL STRAIN; CELL STRUCTURE; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ELECTRIC RESISTANCE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EPITHELIUM CELL; ESCHERICHIA COLI O157; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOFLUORESCENCE MICROSCOPY; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CELL LINE; CLASSIFICATION; DOG; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; PATHOLOGY; PERMEABILITY; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; BACTERIAL ADHESION; CELL LINE; DOGS; EPITHELIAL CELLS; ESCHERICHIA COLI O157; GENE EXPRESSION REGULATION; LACTOBACILLUS RHAMNOSUS; MEMBRANE PROTEINS; PERMEABILITY; PHOSPHOPROTEINS; PROTEIN TRANSPORT;

EID: 42149184871     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00778-07     Document Type: Article

References (48)

1. Amieva, M., and R. Vogelmann. 2004. Epithelial cells and pathogens - the Odyssey System brings light into the darkness. Tight junction barrier function in epithelial cells. http://www.licor.com/bio/PDF/EpithelialCells.pdf. Accessed, 24 August 2006.
2. Balda, M. S., and J. M. Anderson. 1993. Two classes of tight junctions are revealed by ZO-1 isoforms. Am. J. Physiol. 264:C918-C24.
3. Berkes, J., V. K. Viswanathan, S. D. Savkovic, and G. Hecht. 2003. Intestinal epithelial responses to enteric pathogens: effects on tight junction barrier, ion transport, and inflammation. Gut 52:439-451.
4. Boyle, E. C., N. F. Brown, and B. B. Finlay. 2006. Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell. Microbiol. 8:1946-1957.
5. Bradbury, N. A. 2000. Protein kinase-A-mediated secretion of mucin from human colonic epithelial cells. J. Cell Physiol. 185:408-415.
6. Corr, S. C., Y. Li, C. U. Riedel, P. W. O'Toole, C. Hill, and C. G. M. Gahan. 2007. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. USA 104:7617-7621.
7. Doron, S., D. R. Snydman, and S. L. Gorbach. 2005. Lactobacillus GG: bacteriology and clinical applications. Gastroenterol. Clin. N. Am. 34:483-498.
8. FAO/WHO. 2001. Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, Cordoba, Argentina, 1 to 4 October 2001. http://www.fao.org/es/esn/food/foodandfood_probio_en.stm.
9. Finlay, B. B., and M. Caparon. 2005. Bacterial adherence to cell surfaces and extracellular matrix, p. 105-120. In P. Cossart, P. Boquet, S. Normark, and R. Rappuoli (ed.), Cellular microbiology, 2nd ed. ASM Press, Washington, DC.
10. Gorbach, S. L. 2000. Probiotics and gastrointestinal health. Am. J. Gastroenterol. 95:S2-S4.
11. Gotteland, M., S. Cruchet, and S. Verbeke. 2001. Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indomethacin in humans. Aliment. Pharmacol. Ther. 15:11-17.
12. Hansson, G. C. 1988. A blood group B-like pentaglycosylceramide is the major complex glycosphingolipid of the Madin-Darby canine kidney epithelial cell line I (MDCK I). Biochim. Biophys. Acta 967:87-91.
13. Huebner, E. S., and C. M. Surawicz. 2006. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol. Clin. North. Am. 35:355-365.
14. Ingrassia, I., A. Leplingard, and A. Darfeuille-Michaud. 2005. Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl. Environ. Microbiol. 71:2880-2887.
15. Ismaili, A., D. J. Philpott, M. T. Dytoc, R. Soni, S. Ratnam, and P. M. Sherman. 1995. Alpha-actinin accumulation in epithelial cells infected with attaching and effacing gastrointestinal pathogens. J. Infect. Dis. 172:1393-1396.
16. Isolauri, E., H. Majamaa, T. Arvola, I. Rantala, E. Virtanen, and H. Arvilommi. 1993. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 105: 1643-1650.
17. Johnson-Henry, K., J. L. Wallace, N. S. Basappa, R. Soni, G. K. P. Wu, and P. M. Sherman. 2001. Inhibition of attaching and effacing lesion formation following enteropathogenic Escherichia coli and Shiga toxin-producing E. coli infection. Infect. Immun. 69:7152-7158.
18. Johnson-Henry, K. C., K. E. Hagen, M. Gordonpour, T. A. Tompkins, and P. M. Sherman. 2007. Surface layer extracts from Lactobacillus helveticus protect against the effects of enterohemorrhagic Escherichia coli O157:H7 infection. Cell. Microbiol. 9:356-367.
19. Johnson-Henry, K. C., J. D. Riff, M. Gordanpour, and P. M. Sherman. 2005. Probiotics in models of gastrointestinal bacterial infections. Nutrafoods 4:29-36.
20. Johnson-Henry, K. C., M. Nadjafi, Y. Avitzur, D. J. Mitchell, B.-Y. Ngan, E. Galindo-Mata, N. L. Jones, and P. M. Sherman. 2005. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J. Infect. Dis. 191:2106-2117.
21. Johnson-Henry, K. C., D. J. Mitchell, Y. Avitzur, E. Galindo-Mata, N. L. Jones, and P. M. Sherman. 2004. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig. Dis. Sci. 49:1095-1102.
22. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
23. Lee, Y.-K., K.-Y. Puong, A. C. Ouwehand, and S. Salminen. 2003. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J. Med. Microbiol. 52:925-930.
24. Liévin-Le Moal, V., and A. L. Servin. 2006. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev. 19:315-337.
25. Madsen, K., A. Cornish, P. Soper, C. McKaigney, H. Jijon, C. Yachiraec, J. Doyle, L. Jewell, and C. De Simone. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591.
26. Mally, A., M. Decker, M. Bekteshi, and W. Dekant. 2006. Ochratoxin A alters cell adhesion and gap junction intercellular communication in MDCK cells. Toxicology 223:15-25.
27. Mastretta, E., P. Longo, A. Laccisaglia, L. Balbo, R. Russo, A. Mazzaccara, and P. Gianino. 2002. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J. Pediatr. Gastroenterol. Nutr. 35:1046-1049.
28. McCormick, B. A. 2003. The use of transepithelial models to examine host-pathogen interactions. Curr. Opin. Microbiol. 6:77-81.
29. Muza-Moons, M., E. E. Schneeberger, and G. A. Hecht. 2004. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells. Cell. Microbiol. 6:783-793.
30. Otte, J.-M., and D. K. Podolsky. 2004. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am. J. Physiol. 286: G613-G626.
31. Parassol, N., M. Freitas, K. Thoreux, G. Dalmasso, R. Bourdet-Sicard, and P. Rampal. 2005. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res. Microbiol. 156:256-262.
32. Pizarro-Cerdá, J., and P. Cossart. 2006. Bacterial adhesion and entry into host cells. Cell 124:715-727.
33. Reid, G., J. Jass, M. T. Sebulsky, and J. K. McCormick. 2003. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 16:658-672.
34. Resta-Lenert, S., and K. E. Barrett. 2006. Probiotics and commensals reverse TNF-alpha and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130:731-746.
35. Santosa, S., E. Farnworth, and P. J. Jones. 2006. Probiotics and their potential health claims. Nutr. Rev. 64:265-274.
36. Servin, A. L. 2004. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 28:405-440.
37. Sherman, P. M., K. C. Johnson-Henry, H. Yeung, P. Ngo, J. Goulet, and T. A. Tompkins. 2005. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect. Immun. 73:5183-5188.
38. Silva, M., N. V. Jacobus, C. Deneke, and S. L. Gorbach. 1987. Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother. 31:1231-1233.
39. Simonovic, I., J. Rosenberg, A. Koutsouris, and G. Hecht. 2000. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell. Microbiol. 2:305-315.
40. Söderholm, J. D., P. C. Yang, P. Ceponis, A. Vohara, R. Riddell, P. M. Sherman, and M. H. Perdue. 2002. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 123:1099-1108.
41. Söderholm, J. D., and M. H. Perdue. 2001. Stress and the gastrointestinal tract. II. Stress and intestinal barrier function. Am. J. Physiol. Gastrointest. Liver. Physiol. 280:G7-G13.
42. Takahashi, M., H. Taguchi, H. Yamaguchi, T. Osaki, A. Komatsu, and S. Kamiya. 2004. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 41:219-226.
43. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086.
44. Van Itallie, C. M., and J. M. Anderson. 2006. Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 68:403-429.
45. Viswanathan, V. K., A. Koutsouris, S. Lukic, M. Pilkinton, I. Simonovic, M. Simonovic, and G. Hecht. 2004. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect. Immun. 72:3218-3227.
46. Yan, F., H. Cao, T. L. Cover, R. Whitehead, M. K. Washington, and D. B. Polk. 2007. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132:562-575.
47. Zareie, M., J. D. Riff, K. Donato, D. M. McKay, M. H. Perdue, J. D. Soderholm, M. Karmali, M. B. Cohen, J. Hawkins, and P. M. Sherman. 2005. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell. Microbiol. 7:1782-1797.
48. Zareie, M., K. C. Johnson-Henry, J. Jury, P.-C. Yang, B.-Y. Ngan, D. M. McKay, M. H. Perdue, J. D. Soderholm, and P. M. Sherman. 2006. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55:1553-1560.